| Description | PKC-theta inhibitor 1 is an inhibitor of PKCθ (Ki of 6 nM) |
| Target activity | PKCα:1020 μM (ki), PKCδ:392 μM (ki), PKCθ:6 nM (ki), IL-2 production:0.19 μM |
| molecular weight | 348.32 |
| Molecular formula | C17H15F3N4O |
| CAS | 1160501-81-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Collier PN, et al. Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis. ACS Med Chem Lett. 2019 Jun 27;10(8):1134-1139. |